This includes selecting and preparing an appropriate dose with an experienced doctor, properly rotating injection sites on the upper arm, leg, or abdomen according to each patients particular needs, and being aware of possible side effects like dizziness and nausea
Youre not failingyour biology is working against you
The current generation of GLP-1 receptor agonists includes: Semaglutide (weekly subcutaneous injection or oral formulation) Liraglutide (daily subcutaneous injection) Tirzepatide (dual GLP-1/GIP receptor agonist, weekly subcutaneous injection) Each of these GLP-1 agents carries a distinct pharmacological profile, and the optimal choice depends on a patients clinical history, metabolic risk factors, and therapeutic goals a determination best made in consultation with a physician experienced in metabolic and longevity medicine
Microdosing is ideal for those who are looking to: Optimize health, mood, and energy without significant weight loss Stifle chronic inflammation or symptoms of metabolic syndrome Reduce symptoms of autoimmune diseases like rheumatoid arthritis, fibromyalgia, or neurodegenerative disease However, its not suitable for everyone
GLP-1 drugs are FDA-approved for patients with obesity, those who are overweight with related health conditions and those with specific health issues